Adenocarcinoma of the Pancreas Withdrawn Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Adenocarcinoma, Pancreatic / Adenocarcinoma of Pancreas / Pancreas Adenocarcinoma / Adenocarcinoma, Pancreas / Pancreatic Adenocarcinoma / Pancreas, Adenocarcinoma / Adenocarcinoma Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00728000Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaTreatment